Study Links Stopping GLP-1 Drugs to Poorer Heart Health in Type 2 Diabetes
Audio narration · Coming soon
A large study indicates that individuals with type 2 diabetes who begin treatment with GLP-1 drugs and then discontinue them may experience worse heart health outcomes. However, the study emphasizes that further research is necessary to confirm these findings and understand the underlying mechanisms.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews